Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|October 15, 2014
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled EvaluationJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Journal of Hypertension|February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trialsEmily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
Kidney International|December 14, 2012
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitusMuh Geot Wong, Vlado Perkovic, Mark Woodward, et al.
BMJ Open|December 22, 2016
Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT studyKrishnaraj S Rathod, Daniel A Jones, T J A Van-Eijl, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
JAMA|May 15, 2003
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United StatesKatharina Wolf-Maier, Richard S Cooper, José R Banegas, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Heart (British Cardiac Society)|November 29, 2014
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertensionMelvin D Lobo, Mark A de Belder, Trevor Cleveland, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|October 15, 2014
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled EvaluationJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Journal of Hypertension|February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trialsEmily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
Kidney International|December 14, 2012
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitusMuh Geot Wong, Vlado Perkovic, Mark Woodward, et al.
BMJ Open|December 22, 2016
Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT studyKrishnaraj S Rathod, Daniel A Jones, T J A Van-Eijl, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
JAMA|May 15, 2003
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United StatesKatharina Wolf-Maier, Richard S Cooper, José R Banegas, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Heart (British Cardiac Society)|November 29, 2014
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertensionMelvin D Lobo, Mark A de Belder, Trevor Cleveland, et al.
Pageof 18